Welcome to a special election edition of Laboratory Equipment's Friday series, In Case You Missed It (ICYMI). Below, find links to articles that discuss the anticipated impacts of a Donald Trump presidency, with a Republican-controlled House and Senate.


What Election 2016 Means for the Chemistry Enterprise

The election of Donald Trump as U.S. president and a Republican-controlled Congress portend significant impacts to the chemistry enterprise. On the basis of campaign statements, academic researchers are likely to feel a federal research funding pinch while the chemical industry could benefit from new energy policies and relaxed regulation. Budget cuts sought by Republicans would also limit federal regulatory agencies, which could trammel the chemical industry’s expectations for modernized regulation of its products. With tightly limited resources, the Environmental Protection Agency might struggle to implement Congress’ revisions earlier this year to the Toxic Substances Control Act, which had strong backing of the chemical sector.

These are Trump’s Views on Science

Before the election, the non-profit Science Debate sent out a list of 20 science questions to the four candidates. It crowdsourced and refined hundreds of suggestions, then submitted the 20 they deemed most important and most immediate to the presidential campaigns of Clinton, Trump, Gary Johnson and Jill Stein, along with an invitation to the candidates to answer them in writing and discuss them on television. Now that Trump has won the 2016 election, let's take a look at his answers.

Who Will Hold Key Science Leadership Jobs?

Come January, Donald J. Trump will be sworn in as the new president, and dozens of freshly elected lawmakers will join the new Congress (the 115th). What will the election results mean for the leadership of the key agencies and congressional committees that shape U.S. science funding and policy? Here’s a quick guide to who is in, who is out, and who is not going anywhere.

Donald Trump's Election Win Stuns Scientists

Republican businessman and reality-television star Donald Trump will be the United States’ next president. Although science played only a bit part in this year’s dramatic, hard-fought campaign, many researchers expressed fear and disbelief as Trump defeated former secretary of state Hillary Clinton on 8 November.

“Trump will be the first anti-science president we have ever had,” says Michael Lubell, director of public affairs for the American Physical Society in Washington D.C. “The consequences are going to be very, very severe.”

Hubble spots a young cluster of stars. Photo: NASA


Trump Will Probably Undo Obama’s Budget Increases for Earth Sciences

While not much is known about Trump's general space policies beyond a commitment to "global space leadership" and support for commercial spaceflight, his views on Earth science and climate change are largely in line with Republican Congressional appropriators. Funding-wise, NASA's Earth science programs have had a good run under the Obama administration. The agency's Earth science budget has grown by about 50 percent during Obama's tenure, even as much of the rest of NASA's science budget has remained flat.

What Will Trump's Presidency Mean for Our Future in Space?

Editor’s note: this article is very clearly anti-Trump. So take it as you will. But it does speak to space initiatives, so I wanted to include it.

Overall, the space agency will probably be directed to focus more on deep space activities and crewed spaceflight over the next four years, while its top-notch Earth science programs could suffer serious cuts. A few weeks back, the Trump campaign brought on former congressmen Robert Walker to flesh out some talking points. Perhaps the most significant space policy shift Walker discussed at an October 26th meeting of the FAA’s Commercial Space Transportation Advisory Committee was that Trump’s administration would refocus NASA’s budget on “deep space achievements,” while scaling back Earth science research.

Climate change:

Trump Picks Top Climate Skeptic to Lead EPA Transition

Donald Trump has selected one of the best-known climate skeptics to lead his U.S. EPA transition team, according to two sources close to the campaign. Myron Ebell, director of the Center for Energy and Environment at the conservative Competitive Enterprise Institute, is spearheading Trump’s transition plans for EPA, the sources said. Ebell is a well-known and polarizing figure in the energy and environment realm. His participation in the EPA transition signals that the Trump team is looking to drastically reshape the climate policies the agency has pursued under the Obama administration. Ebell has called the Obama administration’s Clean Power Plan for greenhouse gases illegal and said that Obama joining the Paris climate treaty “is clearly an unconstitutional usurpation of the Senate’s authority.”

Could Trump Simply Withdraw U.S. from Paris Climate Agreement?

President-elect Donald Trump now has free rein to make good on his pledge to “cancel” last year’s landmark climate deal. Trump has said throughout this year’s presidential campaign that if elected, he would withdraw the United States from the Paris Agreement, or at least “renegotiate” it. The billionaire climate skeptic has said he would not only disentangle the United States from the deal reached by nearly 200 countries last year near the French capital but also withdraw all funding from the U.N. Framework Convention on Climate Change and redirect climate programming funds to infrastructure projects.


Marijuana Smokes the Competition, Pulls in Key Victories on Election Night

Marijuana was on the ballot in nine states Tuesday, gaining sometimes-sweeping approval in all but one. California, Nevada, Massachusetts and Maine all approved measures legalizing the recreational use of the Schedule I drug, while Florida, Arkansas and North Dakota voted to allow cannabis for medical purposes only. The recreational use of cannabis is now legal in eight states, which are home to almost a quarter of the nation’s overall population. Cannabis for medical use is now legal in 25 states and the District.